open access

Ahead of print
Original Article
Published online: 2020-01-09
Get Citation

The effect of hidden female smoking on the relationship between smoking and cardiovascular disease

Sang Won Hwang, Hae Jeong Lee, Cheol Hong Kim, Sung Hoon Kim, Yechan Kyung, Sang Taek Lee, Ju Suk Lee
DOI: 10.5603/CJ.a2020.0001
·
Pubmed: 31960946

open access

Ahead of print
Original articles
Published online: 2020-01-09

Abstract

Background: Smoking is a known risk factor for cardiovascular morbidity and mortality, but several Korean studies have shown differing results on the association of current smoking status and the risk of cardiovascular disease (CVD). The aim of the present study was to investigate the association between smoking status and CVD (myocardial infarction and stroke) using national representative population-based samples. The aim was also to investigate the effects of hidden smokers on the association between CVD and smoking.

Methods: Data were acquired from 28,620 participants (12,875 men and 15,745 women), age 19 years or older, who participated in the Korea National Health and Nutrition Examination Survey (KNHANES) conducted from 2008 to 2016.

Results: The multivariable logistic regression analysis showed that ex-smoking status was correlated with CVD when self-reported (odds ratio [OR]: 1.62; 95% confidence interval [CI]: 1.20–2.19) and for survey-cotinine verified-smoking status (OR: 1.57; 95% CI: 1.20–2.19). Interestingly, the present study showed current smoking was not significantly associated with CVD. For the effect of sex on smoking and CVD, self-reported and survey-cotinine-verified ex-smoking status were correlated with CVD in males (OR: 1.45; 95% CI: 1.04–2.04 and OR: 1.43; 95% CI: 1.02–2.02) and in females (OR: 2.74; 95% CI: 1.59–4.71 and OR: 2.92; 95% CI: 1.64–5.18). The ratios of cotinine-verified to self-reported smoking rates were 1.95 for women and 1.08 for men.

Conclusions: In the current study, while ex-smoking status was significantly associated with CVD, current smoking status was not. Female ex-smoking status had a higher adjusted odds ratio for CVD than males compared to non-smoking status. An effect of hidden female smoking was also found on the association between smoking status and CVD in Korean adults.

Abstract

Background: Smoking is a known risk factor for cardiovascular morbidity and mortality, but several Korean studies have shown differing results on the association of current smoking status and the risk of cardiovascular disease (CVD). The aim of the present study was to investigate the association between smoking status and CVD (myocardial infarction and stroke) using national representative population-based samples. The aim was also to investigate the effects of hidden smokers on the association between CVD and smoking.

Methods: Data were acquired from 28,620 participants (12,875 men and 15,745 women), age 19 years or older, who participated in the Korea National Health and Nutrition Examination Survey (KNHANES) conducted from 2008 to 2016.

Results: The multivariable logistic regression analysis showed that ex-smoking status was correlated with CVD when self-reported (odds ratio [OR]: 1.62; 95% confidence interval [CI]: 1.20–2.19) and for survey-cotinine verified-smoking status (OR: 1.57; 95% CI: 1.20–2.19). Interestingly, the present study showed current smoking was not significantly associated with CVD. For the effect of sex on smoking and CVD, self-reported and survey-cotinine-verified ex-smoking status were correlated with CVD in males (OR: 1.45; 95% CI: 1.04–2.04 and OR: 1.43; 95% CI: 1.02–2.02) and in females (OR: 2.74; 95% CI: 1.59–4.71 and OR: 2.92; 95% CI: 1.64–5.18). The ratios of cotinine-verified to self-reported smoking rates were 1.95 for women and 1.08 for men.

Conclusions: In the current study, while ex-smoking status was significantly associated with CVD, current smoking status was not. Female ex-smoking status had a higher adjusted odds ratio for CVD than males compared to non-smoking status. An effect of hidden female smoking was also found on the association between smoking status and CVD in Korean adults.

Get Citation

Keywords

smoking, myocardial infarction, stroke, hidden smoker

About this article
Title

The effect of hidden female smoking on the relationship between smoking and cardiovascular disease

Journal

Cardiology Journal

Issue

Ahead of print

Article type

Original Article

Published online

2020-01-09

DOI

10.5603/CJ.a2020.0001

Pubmed

31960946

Keywords

smoking
myocardial infarction
stroke
hidden smoker

Authors

Sang Won Hwang
Hae Jeong Lee
Cheol Hong Kim
Sung Hoon Kim
Yechan Kyung
Sang Taek Lee
Ju Suk Lee

References (30)
  1. McEvoy JW, Blaha MJ, DeFilippis AP, et al. Cigarette smoking and cardiovascular events: role of inflammation and subclinical atherosclerosis from the MultiEthnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol. 2015; 35(3): 700–709.
  2. Bullen C. Impact of tobacco smoking and smoking cessation on cardiovascular risk and disease. Expert Rev Cardiovasc Ther. 2008; 6(6): 883–895.
  3. Mons U, Müezzinler A, Gellert C, et al. Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium. BMJ. 2015; 350: h1551.
  4. Aune D, Schlesinger S, Norat T, et al. Tobacco smoking and the risk of sudden cardiac death: a systematic review and meta-analysis of prospective studies. Eur J Epidemiol. 2018; 33(6): 509–521.
  5. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004; 364(9438): 937–952.
  6. Millett ERC, Peters SAE, Woodward M. Sex differences in risk factors for myocardial infarction: cohort study of UK Biobank participants. BMJ. 2018; 363: k4247.
  7. Peters SAE, Huxley RR, Woodward M. Smoking as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 81 cohorts, including 3,980,359 individuals and 42,401 strokes. Stroke. 2013; 44(10): 2821–2828.
  8. Lee W, Hwang SH, Choi H, et al. The association between smoking or passive smoking and cardiovascular diseases using a Bayesian hierarchical model: based on the 2008-2013 Korea Community Health Survey. Epidemiol Health. 2017; 39: e2017026.
  9. Chang S, Kim H, Kim V, et al. Association between smoking and physician-diagnosed stroke and myocardial infarction in male adults in Korea. Int J Environ Res Public Health. 2016; 13(2): 158.
  10. Jung-Choi KH, Khang YH, Cho HJ. Hidden female smokers in Asia: a comparison of self-reported with cotinine-verified smoking prevalence rates in representative national data from an Asian population. Tob Control. 2012; 21(6): 536–542.
  11. Kim SH, Lee JS. The association of smoking and hypertension according to cotinine-verified smoking status in 25,150 Korean adults. Clin Exp Hypertens. 2019; 41(5): 401–408.
  12. noue S, Zimmet P, Caterson I, et al. The Asia-Pacific perspective: redefining obesity and its treatment. 2000. http://iotf. org (accessed 19 February 2002).
  13. Haufroid V, Lison D. Urinary cotinine as a tobacco-smoke exposure index: a minireview. Int Arch Occup Environ Health. 1998; 71(3): 162–168.
  14. Guerin MR, Higgins CE, Griest WH. The analysis of the particulate and vapour phases of tobacco smoke. IARC Sci Publ. 1987(81): 115–139.
  15. Grassi G, Seravalle G, Calhoun DA, et al. Mechanisms responsible for sympathetic activation by cigarette smoking in humans. Circulation. 1994; 90(1): 248–253.
  16. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol. 2004; 43(10): 1731–1737.
  17. Xu L, Schooling CM, Chan WM, et al. Smoking and hemorrhagic stroke mortality in a prospective cohort study of older Chinese. Stroke. 2013; 44(8): 2144–2149.
  18. Islami F, Mańczuk M, Vedanthan R, et al. A cross-sectional study of cardiovascular disease and associated factors. Ann Agric Environ Med. 2011; 18(2): 255–259.
  19. Prochaska JJ, Benowitz NL. Smoking cessation and the cardiovascular patient. Curr Opin Cardiol. 2015; 30(5): 506–511.
  20. Farley TM, Meirik O, Chang CL, et al. Combined oral contraceptives, smoking, and cardiovascular risk. J Epidemiol Community Health. 1998; 52(12): 775–785.
  21. Chilvers CED, Knibb RC, Armstrong SJ, et al. Post menopausal hormone replacement therapy and risk of acute myocardial infarction--a case control study of women in the East Midlands, UK. Eur Heart J. 2003; 24(24): 2197–2205.
  22. Li C, Engström G, Hedblad Bo, et al. Risk of stroke and hormone replacement therapy. A prospective cohort study. Maturitas. 2006; 54(1): 11–18.
  23. Croft P, Hannaford PC. Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraception study. BMJ. 1989; 298(6667): 165–168.
  24. Assaf AR, Parker D, Lapane KL, et al. Are there gender differences in self-reported smoking practices? Correlation with thiocyanate and cotinine levels in smokers and nonsmokers from the Pawtucket Heart Health Program. J Womens Health (Larchmt). 2002; 11(10): 899–906.
  25. Vartiainen E, Seppälä T, Lillsunde P, et al. Validation of self reported smoking by serum cotinine measurement in a community-based study. J Epidemiol Community Health. 2002; 56(3): 167–170.
  26. Park M, Chesla C. Revisiting Confucianism as a conceptual framework for Asian family study. J Fam Nurs. 2007; 13(3): 293–311.
  27. Schane RE, Glantz SA, Ling PM. Social smoking implications for public health, clinical practice, and intervention research. Am J Prev Med. 2009; 37(2): 124–131.
  28. Husten CG. How should we define light or intermittent smoking? Does it matter? Nicotine Tob Res. 2009; 11(2): 111–121.
  29. Gawlik KS, Melnyk BM, Tan A. An epidemiological study of population health reveals social smoking as a major cardiovascular risk factor. Am J Health Promot. 2018; 32(5): 1221–1227.
  30. Bjartveit K, Tverdal A. Health consequences of smoking 1-4 cigarettes per day. Tob Control. 2005; 14(5): 315–320.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl